Literature DB >> 23548715

Recent advances in research of HIV infection: implications of viral and host genetics on treatment and prevention.

R E Haaland1, J A Johnson, J Tang.   

Abstract

The genetic diversity among human immunodeficiency virus (HIV) subtypes as well as the variability of viral sequences found in HIV-infected individuals presents a number of difficult obstacles for the development of universally effective HIV treatment and prevention methods. Here, we present a brief summary of recent developments in the analysis of viral genetics and human genomics to provide insight into future methods for HIV treatment and prevention. Recent studies have mined viral sequences found in newly infected individuals to identify common features of all transmitted viruses that could provide potential targets for HIV vaccine development. Analysis of human immunogenetics has identified specific alleles associated with reduced virus loads in HIV-infected individuals providing valuable information that may influence individual responses to treatment and prevention methods. Increased sensitivity of antiretroviral drug resistance testing has improved the detection of hidden drug resistant virus but also highlighted the potential for drug resistant viruses to reduce the effectiveness of clinical treatment regimens. The rapidly expanding amount of data generated by studies of viral genetics and human immunogenetics will provide valuable information to guide the design of new strategies to improve clinical treatment and enhance HIV vaccine development.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548715      PMCID: PMC5545684          DOI: 10.1159/000345935

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  35 in total

1.  HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.

Authors:  Robert Paris; Sasitorn Bejrachandra; Prasert Thongcharoen; Sorachai Nitayaphan; Punnee Pitisuttithum; Anna Sambor; Sanjay Gurunathan; Donald Francis; Silvia Ratto-Kim; Chitraporn Karnasuta; Mark S de Souza; Victoria R Polonis; Arthur E Brown; Jerome H Kim; Henry A Stephens
Journal:  Vaccine       Date:  2011-11-12       Impact factor: 3.641

2.  Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.

Authors:  Elias K Halvas; Grace M Aldrovandi; Peter Balfe; Ingrid A Beck; Valerie F Boltz; John M Coffin; Lisa M Frenkel; J Darren Hazelwood; Victoria A Johnson; Mary Kearney; Andrea Kovacs; Daniel R Kuritzkes; Karin J Metzner; Dwight V Nissley; Marek Nowicki; Sarah Palmer; Rainer Ziermann; Richard Y Zhao; Cheryl L Jennings; James Bremer; Don Brambilla; John W Mellors
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

3.  Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.

Authors:  S Palmer; V Boltz; N Martinson; F Maldarelli; G Gray; J McIntyre; J Mellors; L Morris; J Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

Review 4.  Identifying and characterizing recently transmitted viruses.

Authors:  Brandon F Keele
Journal:  Curr Opin HIV AIDS       Date:  2010-07       Impact factor: 4.283

5.  Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.

Authors:  Paul J McLaren; Stephan Ripke; Kimberly Pelak; Amy C Weintrob; Nikolaos A Patsopoulos; Xiaoming Jia; Rachel L Erlich; Niall J Lennon; Carl M Kadie; David Heckerman; Namrata Gupta; David W Haas; Steven G Deeks; Florencia Pereyra; Bruce D Walker; Paul I W de Bakker
Journal:  Hum Mol Genet       Date:  2012-06-19       Impact factor: 6.150

6.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.

Authors:  Morgane Rolland; Sodsai Tovanabutra; Allan C deCamp; Nicole Frahm; Peter B Gilbert; Eric Sanders-Buell; Laura Heath; Craig A Magaret; Meera Bose; Andrea Bradfield; Annemarie O'Sullivan; Jacqueline Crossler; Teresa Jones; Marty Nau; Kim Wong; Hong Zhao; Dana N Raugi; Stephanie Sorensen; Julia N Stoddard; Brandon S Maust; Wenjie Deng; John Hural; Sheri Dubey; Nelson L Michael; John Shiver; Lawrence Corey; Fusheng Li; Steve G Self; Jerome Kim; Susan Buchbinder; Danilo R Casimiro; Michael N Robertson; Ann Duerr; M Juliana McElrath; Francine E McCutchan; James I Mullins
Journal:  Nat Med       Date:  2011-02-27       Impact factor: 53.440

Review 7.  Host genetics and HIV-1: the final phase?

Authors:  Jacques Fellay; Kevin V Shianna; Amalio Telenti; David B Goldstein
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

Review 8.  Viral determinants of HIV-1 macrophage tropism.

Authors:  Christopher J A Duncan; Quentin J Sattentau
Journal:  Viruses       Date:  2011-11-15       Impact factor: 5.048

9.  HIV control through a single nucleotide on the HLA-B locus.

Authors:  Henrik N Kløverpris; Mikkel Harndahl; Alasdair J Leslie; Jonathan M Carlson; Nasreen Ismail; Mary van der Stok; Kuan-Hsiang Gary Huang; Fabian Chen; Lynn Riddell; Dewald Steyn; Dominique Goedhals; Cloete van Vuuren; John Frater; Bruce D Walker; Mary Carrington; Thumbi Ndung'u; Søren Buus; Philip Goulder
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

10.  Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.

Authors:  Jeffrey A Johnson; Jin-Fen Li; Xierong Wei; Jonathan Lipscomb; Diane Bennett; Ashley Brant; Mian-Er Cong; Thomas Spira; Robert W Shafer; Walid Heneine
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more
  5 in total

1.  CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data.

Authors:  Jianming Tang; Xuelin Li; Matthew A Price; Eduard J Sanders; Omu Anzala; Etienne Karita; Anatoli Kamali; Shabir Lakhi; Susan Allen; Eric Hunter; Richard A Kaslow; Jill Gilmour
Journal:  Front Microbiol       Date:  2015-07-01       Impact factor: 5.640

2.  Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection.

Authors:  Leonard Moise; Frances Terry; Andres H Gutierrez; Ryan Tassone; Phyllis Losikoff; Stephen H Gregory; Chris Bailey-Kellogg; William D Martin; Anne S De Groot
Journal:  Front Microbiol       Date:  2014-10-06       Impact factor: 5.640

3.  HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China.

Authors:  Bin Lin; Xiaoguang Sun; Shengli Su; Cuixia Lv; Xiaofei Zhang; Lin Lin; Rui Wang; Jihua Fu; Dianmin Kang
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

4.  Demographic characteristics associated with the use of HIV pre-exposure prophylaxis (PrEP) in an urban, community health center.

Authors:  Mitchell Caponi; Carolyne Burgess; Alexandra Leatherwood; Luis Freddy Molano
Journal:  Prev Med Rep       Date:  2019-05-14

5.  Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive study.

Authors:  Hongshuai Sui; Tao Gui; Lei Jia; Wei Guo; Jingwan Han; Yongjian Liu; Zuoyi Bao; Hanping Li; Jingyun Li; Lin Li
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.